Humira news from FiercePharma
News
FDA checks arthritis meds for child-cancer link
In a development sure to spawn headlines across the country, the FDA is looking into a possible link between autoimmune drugs such as Remicade and Humira -- known as TNF blockers for their action Read more...
Alzheimer's: A new indication for Enbrel?
For yet another example of the trend toward teaching old drugs new tricks, check out Exhibit E for Enbrel. According to research released today, the anti-rheumatoid arthritis med has shown an Read more...
ALSO NOTED: Did Merck, Schering withhold Zetia data?;Genentech gives eye docs access to Avastin
> Merck and Schering-Plough research raised questions about potential liver damage from their popular cholesterol med Zetia--but the companies never published those studies. News about this Read more...
ALSO NOTED: NICE rejects Remicade for ankylosing spondylitis; Mom sues drugmaker over infant's death;
> Britain's National Institute for Clinical Excellence rejected Schering-Plough's Remicade as a treatment for ankylosing spondylitis, recommending Abbott's Humira and Wyeth's Enbrel instead. Read more...
NICE snubs Orencia, picks 3 rivals
It's final: Britain's National Health Service won't pay for Bristol-Myers Squibb's anti-arthritis drug Orencia. Patient advocacy groups had been lobbying the National Institute for Health and Read more...
Antibody sales growing fastest
Looking for pharma growth? Here it is--in monoclonal antibodies. A new Datamonitor report projects 14 percent annual growth in the market for the antibody drugs, which mimic the body's own immune Read more...
SPOTLIGHT: NHS approves drugs
British patients on the National Health Service will get access to two intensive arthritis therapies: MabThera, made by Roche; and Humira, made by Abbott Laboratories. Patient advocacy groups have Read more...
Get more Humira coverage at:
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends